Clinical Trial Update: Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating psilocybin in patients with Alcohol Use Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Zurich | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED